Differential CCR4 Expression and function in cutaneous T-cell lymphoma cell lines

Kaohsiung Journal of Medical Sciences

Volumn 24, Issue 11, 2008, Pages 577-590

  Wu, Chieh Shan ^a   Wang, Si Ting ^b   Liao, Chai Yu ^b   Wu, Meng Tse ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

CCR4; Chemokine; Cutaneous T cell lymphoma

Indexed keywords

ALPHA4 INTEGRIN; BETA1 INTEGRIN; CHEMOKINE RECEPTOR CCR4; MACROPHAGE DERIVED CHEMOKINE;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL SPECIFICITY; CHEMOTAXIS; CONTROLLED STUDY; CULTURE MEDIUM; CUTANEOUS T CELL LYMPHOMA; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE MIGRATION; LYMPHOMA CELL LINE; MEMORY T LYMPHOCYTE; MYCOSIS FUNGOIDES; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEZARY SYNDROME; SIGNAL TRANSDUCTION;

EID: 63049133087     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(09)70019-1     Document Type: Article

References (42)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768-85.
2. Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 1999; 341:1817-28.
3. Zollner TM, Asadullah K, Schon MP. Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach? Exp Dermatol 2007;16:1-12.
4. Kakinuma T, Nakamura K, Wakugawa M, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-41.
5. Heald PW, Yan SL, Edelson RL, et al. Skin-selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma. J Invest Dermatol 1993;101:222-6
6. Shiohara T, Moriya N, Gotoh C, et al. Differential expression of lymphocyte function-associated antigen 1 (LFA-1) on epidermotropic and non-epidermotropic T-cell clones. J Invest Dermatol 1989;93:804-8.
7. Hwang ST, Fitzhugh DJ. Aberrant expression of adhesion molecules by Sezary cells: functional consequences under physiologic shear stress conditions. J Invest Dermatol 2001;116:466-70.
8. Kallinich T, Muche JM, Qin S, et al. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol 2003;121:1045-52.
9. Kakinuma T, Sugaya M, Nakamura K, et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 2003;48:23-30.
10. Starkebaum G, Loughran TP Jr, Waters CA, et al. Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor. Int J Cancer 1991;49:246-53.
11. Gootenberg JE, Ruscetti FW, Mier JW, et al. Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J Exp Med 1981;154:1403-18.
12. Popovic M, Sarin PS, Robert-Gurroff M, et al. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 1983;219:856-9.
13. Weiss A, Wiskocil RL, Stobo JD. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol 1984; 133:123-8.
14. Wiley HE, Gonzalez EB, Maki W, et al. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 2001;93:1638-43.
15. Wu MT, Hwang ST. CXCR5-transduced bone marrow-derived dendritic cells traffic to B cell zones of lymph nodes and modify antigen-specific immune responses. J Immunol 2002;168:5096-102.
16. Notohamiprodjo M, Segerer S, Huss R, et al. CCR10 is expressed in cutaneous T-cell lymphoma. Int J Cancer 2005;115:641-7.
17. Shamri R, Grabovsky V, Gauguet JM, et al. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol 2005;6:497-506.
18. Wu M, Fang H, Hwang ST. Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells. J Immunol 2001;167:4791-5.
19. Rose DM, Cardarelli PM, Cobb RR, Ginsberg MH. Soluble VCAM-1 binding to alpha4 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells. Blood 2000;95:602-9.
20. Garcia-Bernal D, Wright N, Sotillo-Mallo E, et al. Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha 4 beta 1. Mol Biol Cell 2005;16:3223-35.
21. Chan JR, Hyduk SJ, Cybulsky MI. Alpha 4 beta 1 integrin/VCAM-1 interaction activates alpha L beta 2 integrin-mediated adhesion to ICAM-1 in human T cells. J Immunol 2000;164:746-53.
22. Ades EW, Candal FJ, Swerlick RA, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992;99:683-90.
23. Till KJ, Lin K, Zuzel M, et al. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood 2002;99:2977-84.
24. Arroyo AG, Sanchez-Mateos P, Campanero MR, et al. Regulation of the VLA integrin-ligand interactions through the beta 1 subunit. J Cell Biol 199;117:659-70.
25. Chan JR, Hyduk SJ, Cybulsky MI. Chemoattractants induce a rapid and transient upregulation of monocyte alpha4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest an early step in the process of emigration. J Exp Med 2001;193:1149-58.
26. Ferenczi K, Fuhlbrigge RC, Pinkus J, et al. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 2002;119:1405-10.
27. Katou F, Ohtani H, Nakayama T, et al. Macrophage-derived chemokine (MDC/ CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue. Am J Pathol 2001;158:1263-70.
28. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001;250:91-104.
29. Chen GS, Yu HS, Lan CC, et al. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Br J Dermatol 2006;154: 910-8.
30. Saeki H, Tamaki K. Thymus and activaion regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006;43:75-84.
31. D'Ambrosio D, Albanesi C, Lang R, et al. Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion. J Immunol 2002;169:2303-12.
32. Mariani M, Lang R, Binda E, et al. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. Eur J Immunol 2004;34:231-40.
33. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-9.
34. Cronshaw DG, Owen C, Brown Z, et al. Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxis. J Immunol 2004;172: 7761-70.
35. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med 2004;350:1978-88.
36. Berger CL, Hanlon D, Kanada D, et al. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Blood 2002;99:2929-39.
37. Berger CL, Tigelaar R, Cohen J, et al. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 2005;105:1640-7.
38. Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 2005;5: 546-59.
39. Schechner JS, Edelson RL, McNiff JM, et al. Integrins alpha 4 beta 7 and alpha E beta 7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis. Lab Invest 1999;79:601-7.
40. Laudanna C, Alon R. Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes. Thromb Haemost 2006;95:5-11.
41. Narducci MG, Scala E, Bresin A, et al. Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/ dipeptidylpeptidase IV. Blood 2006;107:1108-15.
42. Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 2006;97: 1139-46.